Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,497-2,508 of 4,306
Drug study icon
WithdrawnNCT02603458

NRX-1074 in Early Course Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Other study type icon
CompletedNCT00758251

Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bauska
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Latvia
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
TerminatedNCT00931996

Oculomotor and Spatial Cognition Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 15 Years to 64 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
Schizophrenia
Drug study icon
CompletedNCT02704962

Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

This summary needs review. Please check the official study record and contact the research team for details.

In Kaohsiung City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Taiwan
Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00585390

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 8 Years to 25 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00964041

Once Weekly D-cycloserine for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT01549041

Once-Daily Asenapine for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Butner
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Duke University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00046085

Online Family Support and Education for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.